Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Taylor Farms Outbreaks Show Limits Of US Ability to Safeguard Produce From Mexico

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

US Health Agency Moves to Increase Oversight Of Food Additives

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

Diffuse Axial Pain Linked to Peripheral Arthritis

The anatomical pattern of inflammatory back pain at disease onset may reveal which patients face a heightened risk for joint complications years later.

Acupuncture for IBS: Does It Really Help?

Acupuncture was tied to higher response rate, lower symptom severity, and better quality of life in IBS treatment, but doubts about reproducible efficacy remain.

TACE Plus Ablation Boosts Overall Survival in Liver Cancer

Combining transarterial chemoembolization with subsequent thermal ablation more than doubled PFS and overall survival in patients with liver-confined hepatocellular carcinoma ineligible for curative treatment.

Acting US FDA Chief Urges Confidence in Lettuce as Agency Updates Produce Safety Guidance

Acting U.S. FDA Commissioner Kyle Diamantas said on Tuesday Americans should feel confident in eating fresh produce, as the agency has finalized guidance for proper...

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

The anatomical pattern of inflammatory back pain at disease onset may reveal which patients face a heightened risk for joint complications years later.

Acupuncture was tied to higher response rate, lower symptom severity, and better quality of life in IBS treatment, but doubts about reproducible efficacy remain.

Combining transarterial chemoembolization with subsequent thermal ablation more than doubled PFS and overall survival in patients with liver-confined hepatocellular carcinoma ineligible for curative treatment.

Acting U.S. FDA Commissioner Kyle Diamantas said on Tuesday Americans should feel confident in eating fresh produce, as the agency has finalized guidance for proper...

News All Time

Small Colorectal Lesions Carry Risk for Deep Invasion

Non-pedunculated colorectal lesions smaller than 2 cm may harbor deep submucosal invasion despite their diminutive size, study finds.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Does Doublet Chemotherapy Improve Survival in Rectal Cancer?

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Creatinine Assay Bias Affects MELD Scoring

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

EHR Marker May Help Curb Risk for Liver Transplant Rejection

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune Drug Cuts Heavy Drinking in Mid-stage Trial for Alcohol Use Disorder

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

Newer Antibiotics Show No Clear Benefit for Staph Infections

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

FDA Approves Freenome's Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

Company At Center Of US Cyclospora Outbreak Complained to White House, Source Says

U.S. produce supplier Taylor Farms complained to White House and Food and Drug Administration officials about the government's inspection process earlier this month, a...

Poultry Firm Recalls Nearly 1.6 Million Dozen Eggs Over Salmonella Risk, FDA Says

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

Simple Risk Score Is the Best at Detecting Liver Fibrosis

The LiverRisk score outperformed the fibrosis-4 index for detecting moderate or greater fibrosis across all age groups, particularly in younger adults.

CRC Screening in Adults Under 50: Research Reveals Trends

After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how providers are reaching those patients.

How to Predict Iron Therapy Response in IBD

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

Anxiety May Undermine Treatment Response in Some GERD Cases

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

‘A Tiny Blueberry’: How Ingestible Sensors Keep Shrinking

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Recommended News For You

Lung cancer screening adherence rates decline annually after baseline screening

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

Recommended Articles For You

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis 

All About Ferric Gluconate – The Best Source Of Iron For Anemia 

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

2.

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

3.

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

4.

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

5.

Liver cancer survival rates reflect income disparities

1.

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition

2.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

3.

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More

4.

Innovative Approaches in Oncology for Modern Medicine

5.

Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

3.

Updates on Standard V/S High Risk Myeloma Treatment

4.

Best Practices in Hematology

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot